Pharma Journalist -

Asklepios BioPharmaceutical, Inc. (AskBio) announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research…
Read More...

Aptar and Sonmol have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases. This collaboration will initially…
Read More...

Mogrify Ltd (Mogrify), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo), a…
Read More...

Boehringer Ingelheim announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults. The…
Read More...

Nexus Pharmaceuticals announced that it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, the first and only…
Read More...

Novartis announced new Mayzent (siponimod) data in the April supplemental issue of Neurology, the medical journal of the American Academy of Neurology. The data build on existing…
Read More...

Gilead Sciences, Inc. Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery and…
Read More...

Hope Biosciences announces FDA approval on their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River…
Read More...

SMi reports: Exclusive Chair letter invite released for inaugural Pre-filled Syringes San Francisco, USA this September SMi Group is delighted to announce the inaugural Pre-filled…
Read More...

Anixa Biosciences, Inc. announced that it has entered into a strategic collaboration with OntoChem GmbH to discover and develop anti-viral drug candidates for COVID-19. Dr. Amit…
Read More...